Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients

Mallamaci, Francesca; Zoccali, Carmine; Tripepi, Giovanni; Fermo, Isabella; Benedetto, Francesco A; Cataliotti, Alessandro; Bellanuova, Ignazio; Malatino, Lorenzo Salvatore; Soldarini, Armando
February 2002
Kidney International;Feb2002, Vol. 61 Issue 2, p609
Academic Journal
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.. Background: We prospectively tested the prediction power of homocysteinemia for all-cause and cardiovascular outcomes in a cohort of 175 hemodialysis patients followed for 29 ± 12 months. Methods: Survival analysis was performed by the Cox's proportional hazard model and data were expressed as hazard ratio and 95% confidence interval (CI). Results: During the follow-up period 51 patients died, 31 of them (61%) of cardiovascular causes and 16 patients developed non-fatal atherothrombotic complications. Plasma total homocysteine was an independent predictor of cardiovascular mortality (P = 0.01). Combined analysis of fatal and non-fatal atherothrombotic events showed that homocysteine was a strong and independent predictor of these outcomes because the risk of these events was 8.2 times higher (95% CI 1.9 to 32.2) in patients in the third homocysteine tertile than in those in the first tertile (P = 0.005). Conclusions: There is a clear association between hyperhomocysteinemia and incident cardiovascular mortality and atherothrombotic events in hemodialysis patients. Intervention studies are needed to determine whether the accumulation of this substance has a causal role in the pathogenesis of cardiovascular damage in patients undergoing hemodialysis.


Related Articles

  • Homocysteine metabolism in renal failure. van Guldener, Coen; Stam, Frank; Stehouwer, Coen D.A. // Kidney International Supplement;Feb2001, Issue 78, pS-234 

    Investigates the metabolism of homocysteine in chronic renal failure. Role of hyperhomocysteinemia in the progression of atherothrombotic disease; Relationship between glomerular filtration rate and plasma homocysteine level; Impairment of homocysteine remethylation in dialysis patients.

  • Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971–2000). Iseki, Kunitoshi; Tozawa, Masahiko; Iseki, Chiho; Takishita, Shuichi; Ogawa, Yoshihide // Kidney International;Feb2002, Vol. 61 Issue 2, p668 

    Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971–2000).. Background: The clinical demographics of chronic dialysis patients are changing worldwide. However, long-term data from regional dialysis registries have not yet been analyzed and reported. Methods: The...

  • Survival advantage in Asian American end-stage renal disease patients1. Wong, Joyce S.; Port, Friedrich K.; Hulbert-Shearon, Tempie E.; Carroll, Caitlin E.; Wolfe, Robert A.; Agodoa, Lawrence Y.C.; Daugirdas, John T. // Kidney International;Jun1999, Vol. 55 Issue 6, p2515 

    Survival advantage in Asian American end-stage renal disease patients. Background. An earlier study documented a lower mortality risk for end-stage renal disease (ESRD) patients in Japan compared with the United States. We compared the mortality of Caucasian (white) and Asian American dialysis...

  • Survival of Dialysis Patients Using Random Survival Forest Model in Low-Dimensional Data with Few-Events. Rafati, Shideh; Baneshi, Mohammad Reza; Hassani, Laleh; Bahrampour, Abbas // Journal of Kerman University of Medical Sciences;Nov/Dec2019, Vol. 26 Issue 6, p450 

    Background:Dialysis is a process for eliminating extra uremic fluids of patients with chronic renal failure. The present study aimed to determine the variables that influence the survival of dialysis patients using random survival forest model (RSFM) in low-dimensional data with low events per...

  • Coronary risk factors in maintenance hemodialysis patients: Who is the culprit - hemodialysis or chronic renal failure? Gupta, Kapil; Mahajan1, Rajiv // International Journal of Applied & Basic Medical Research;Mar2011, Vol. 1 Issue 1, p11 

    Objective: Dyslipidemia, common in uremic patients subjected to maintenance hemodialysis (HD), represents an independent risk factor for atherosclerosis; but the association between long-term HD and uremic dyslipidemia is not crystal clear. The present study was aimed to ascertain any...

  • Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. Helga Stopper; Anna-Teresa Treutlein; Udo Bahner; Nicole Schupp; Ursula Schmid; Andreas Brink; Alessandra Perna; August Heidland // Nephrology Dialysis Transplantation;Oct2008, Vol. 23 Issue 10, p3272 

    Background. Cancer incidence and genomic damage of peripheral lymphocytes are elevated in patients with end-stage renal failure. Among other uraemic toxins, homocysteine (Hcy) levels are increased in most of these patients. In healthy individuals, plasma Hcy correlates with the degree of genomic...

  • Omega-3 and Serum Homocysteine Level in Hemodialysis Patients. Savaj, Shokoufeh // Iranian Journal of Kidney Diseases;Nov2013, Vol. 7 Issue 6, p421 

    The author discusses the role of omega-3 fatty acid and serum homocysteine level in hemodialysis for patients with end-stage renal disease. He explores several studies that reveal the risk factors and high prevalence of hyperhomocysteinemia in hemodialysis patients. The author reveals that fatty...

  • Uremic Restless Legs Syndrome (RLS) and Sleep Quality in Patients With End-Stage Renal Disease on Hemodialysis: Potential Role of Homocysteine and Parathyroid Hormone. Gade, Katrin; Blaschke, Sabine; Rodenbeck, andrea; Becker, andreas; anderson-Schmidt, Heike; Cohrs, Stefan // Kidney & Blood Pressure Research;Nov2013, Vol. 37 Issue 4/5, p458 

    Background: The aetiology of uremic restless legs syndrome (RLS) remains unclear. Our research investigated whether an elevated plasma concentration of the excitatory amino acid homocysteine might be associated with RLS occurrence in patients with chronic renal insufficiency on hemodialysis....

  • No net renal extraction of homocysteine in fasting humans. van Guldener, Coen; Donker, J.M.; Jakobs, Cornelis; Teerlink, Tom; de Meer, Kees; Stehouwer, Coen D.A. // Kidney International;Jul1998, Vol. 54 Issue 1, p166 

    Describes the real extraction of homocysteine in fasting humans. Measurement of plasma and free homocysteine; Mechanism of hyperhomocysteinemia in chronic renal failure; Examination of renal amino acid metabolism.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics